Treatment-Resistant Depression: When Standard Treatment Isn’t Enough

Treatment-resistant depression, or TRD, is generally defined as depression that has not responded adequately to at least two antidepressant trials, each at an adequate dose for an adequate duration. It is more common than many people realize — in the large STAR*D study, about a third of people treated for major depressive disorder had not reached full remission after up to four treatment steps.

For the person experiencing it, the label often lands badly. It sounds like a verdict. Before accepting it as one, several things are worth examining, and a psychiatric evaluation in New Jersey that revisits the fundamentals frequently changes the picture.

Before Accepting a TRD Diagnosis

The term assumes the treatment was adequate and the diagnosis was correct. Both assumptions deserve scrutiny.

Was the trial actually adequate? An adequate trial generally means a therapeutic dose sustained for six to eight weeks. Many trials that are counted as failures were stopped early because of side effects, never titrated to a therapeutic dose, or taken inconsistently. A medication that was taken at a starting dose for three weeks has not failed. It has not been tested.

Is the diagnosis correct? This is the most consequential question. Unrecognized bipolar spectrum disorder is one important reason antidepressants may not work — antidepressant monotherapy in bipolar depression frequently produces partial response, no response, or destabilization. Unrecognized ADHD, trauma-related conditions, and personality-level difficulties can all produce depressive presentations that do not respond to antidepressants alone.

Is something medical contributing? Thyroid dysfunction, vitamin D and B12 deficiency, iron deficiency, sleep apnea, and certain medications can all produce or sustain depressive symptoms. These are straightforward to evaluate and are sometimes the entire explanation.

Is substance use involved? Alcohol in particular can worsen depression and get in the way of treatment, and its role is easy to underestimate.

Is there an untreated maintaining factor? An abusive relationship, chronic pain, financial crisis, or unaddressed trauma will limit what medication can accomplish.

When people describe cycling through medications without improvement, the medication is often not the problem. The formulation of the problem is. This is a reasonable basis to seek a second opinion psychiatrist in NJ rather than a fourth medication trial.

What Adequate Treatment Actually Requires

Where the diagnosis is confirmed and the trials were genuinely adequate, the evidence-based options are broader than most people are told.

Optimization. Increasing to the maximum tolerated dose before switching. Partial responders frequently improve with dose adjustment alone.

Switching. Moving to a different agent, sometimes within class and sometimes across class. Failure of one SSRI does not predict failure of another.

Augmentation. Adding a second agent to an antidepressant that has produced partial response. Atypical antipsychotics such as aripiprazole and quetiapine have the strongest evidence base for this. Lithium and thyroid hormone augmentation both have long-standing evidence. Bupropion is commonly added to an SSRI, particularly where anhedonia or fatigue is prominent.

Combining with psychotherapy. Where medication alone has been the approach, adding structured psychotherapy meaningfully improves outcomes, and this is one of the more consistently underused steps.

Newer and More Intensive Options

For depression that persists through several adequate trials, additional options exist.

Esketamine and ketamine. Intranasal esketamine is FDA-approved for treatment-resistant depression and is administered under supervision in certified settings. Response is frequently rapid compared with conventional antidepressants, though maintenance treatment is generally required.

Transcranial magnetic stimulation. TMS is a noninvasive, FDA-approved outpatient treatment for treatment-resistant depression, delivered over a course of several weeks. It does not involve anesthesia and has a favorable side-effect profile relative to medication.

Electroconvulsive therapy. ECT remains among the most effective treatments available for severe depression, particularly with psychotic features or acute risk. Its reputation substantially predates modern practice, and it is worth discussing accurately rather than dismissing.

Access to these varies, and referral pathways differ. A South Jersey psychiatrist or any provider managing complex depression should be able to describe what is available and what the referral process involves.

What This Means If You Are in It

The most important point is that TRD is a description of a treatment history, not a statement about a person. It does not mean nothing will work. It frequently means that something in the formulation has not yet been identified.

The people who do best are generally those whose diagnosis gets revisited rather than assumed, whose medical contributors get evaluated, and whose treatment history gets reconstructed carefully enough to distinguish genuine failures from inadequate trials.

Frequently Asked Questions

What counts as treatment-resistant depression?

The common definition is inadequate response to at least two antidepressant trials, each at a therapeutic dose for six to eight weeks. The definition matters because many trials counted as failures did not meet that standard — they were stopped early for side effects, never titrated up, or taken inconsistently. Reconstructing the actual treatment history is usually the first step, and it frequently changes the assessment.

Why have antidepressants not worked for me?

There are several common reasons beyond genuine treatment resistance. The most consequential is an incorrect diagnosis, particularly unrecognized bipolar spectrum disorder, since antidepressants alone often do not work in bipolar depression and can destabilize mood. Others include inadequate dose or duration, untreated medical contributors such as thyroid or sleep disorders, alcohol use, and ongoing circumstances that medication cannot address. Each of these is worth evaluating before concluding that medication does not work for you.

Is it worth getting a second opinion for depression that is not improving?

Frequently, yes. A second opinion is not a criticism of previous care. Its value is that it revisits the diagnosis and the treatment history with fresh attention, and diagnostic reconsideration is one of the more common reasons treatment eventually succeeds after multiple failed trials. It is reasonable to seek one after two or three adequate trials without meaningful improvement.

What are the options if medication has not worked?

Options include optimizing the dose, switching agents, augmenting with a second medication such as an atypical antipsychotic or lithium, and adding structured psychotherapy if it has not been part of treatment. For depression that persists through several adequate trials, esketamine, transcranial magnetic stimulation, and electroconvulsive therapy are established treatments with substantial evidence. Which of these is appropriate depends on the specific clinical picture.

If you have been through several medication trials without meaningful improvement, the more useful next question is often not which medication to try next, but whether the underlying picture has been fully examined.

This article is for general educational purposes only. It does not constitute medical advice, does not establish a provider-patient relationship, and is not a substitute for individual evaluation, diagnosis, or treatment by a qualified clinician. If you’re in crisis or thinking about harming yourself, call or text 988 (Suicide & Crisis Lifeline), any time, day or night. In an emergency, call 911 or go to the nearest emergency room.